Immix Biopharma (IMMX) Institutional Ownership $2.04 -0.02 (-0.97%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Immix Biopharma (NASDAQ:IMMX)CurrentInstitutional OwnershipPercentage11.26%Number ofInstitutional Buyers(last 12 months)9TotalInstitutional Inflows(last 12 months)$1.23MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$627.43K Get IMMX Insider Trade Alerts Want to know when executives and insiders are buying or selling Immix Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data IMMX Institutional Buying and Selling by Quarter Immix Biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails1/13/2025 FNY Investment Advisers LLC28,750$63K0.0%N/A0.105% 11/16/2024Geode Capital Management LLC150,082$224K0.0%+5.6%0.546% 10/22/2024Private Advisor Group LLC34,325$51K0.0%-47.3%0.130% 8/16/2024Invst LLC27,000$57K0.0%N/A0.102% 8/12/2024XTX Topco Ltd17,663$35K0.0%-66.2%0.067% 8/9/2024Renaissance Technologies LLC154,685$306K0.0%-41.7%0.586% 8/7/2024AIGH Capital Management LLC1,406,680$2.79M0.9%-9.5%5.326% 5/10/2024Tocqueville Asset Management L.P.37,800$116K0.0%+89.0%0.143% 4/26/2024Tritonpoint Wealth LLC24,526$75K0.0%N/A0.093% 2/7/2024Jump Financial LLC18,500$128K0.0%N/A0.093% Get the Latest News and Ratings for IMMX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Immix Biopharma and its competitors with MarketBeat's FREE daily newsletter. 2/6/2024Private Advisor Group LLC99,775$690K0.0%N/A0.502% 2/1/2024OLD National Bancorp IN10,000$69K0.0%N/A0.050% 1/30/2024Imprint Wealth LLC34,483$239K0.2%+49.4%0.174% 11/9/2023Tocqueville Asset Management L.P.12,000$41K0.0%N/A0.061% 10/23/2023Commonwealth Equity Services LLC28,855$99K0.0%+26.4%0.147% 7/28/2023 Koshinski Asset Management Inc.51,001$137K0.0%N/A0.339% 7/25/2023 UMB Bank n.a.72,639$195K0.0%-26.8%0.483% 4/11/2023 UMB Bank n.a.99,300$181K0.0%N/A0.714% 2/10/2023Murchinson Ltd.67,200$154K0.0%N/A0.482% 2/7/2023Lynwood Capital Management Inc.25,000$58K0.1%N/A0.179% 2/1/2023Bank of Montreal Can15,000$36K0.0%N/A0.108% 5/11/2022InterOcean Capital Group LLC15,900$38K0.0%N/A0.115% 2/14/2022Altium Capital Management LP122,388$436K0.1%N/A1.616% 2/14/2022Murchinson Ltd.695,600$2.48M0.2%N/A9.183% 2/9/2022Context Capital Management LLC11,532$41K0.0%N/A0.152% 2/2/2022PVG Asset Management Corp20,000$71K0.3%N/A0.264% 2/1/2022Eidelman Virant Capital29,856$103K0.0%N/A0.394% (Data available from 1/1/2016 forward) IMMX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IMMX shares? During the previous two years, 18 institutional investors and hedge funds held shares of Immix Biopharma. The most heavily invested institutionals were AIGH Capital Management LLC ($2.79M), Renaissance Technologies LLC ($306K), Imprint Wealth LLC ($239K), Geode Capital Management LLC ($224K), UMB Bank n.a. ($195K), Murchinson Ltd. ($154K), and Koshinski Asset Management Inc. ($137K).Learn more on IMMX's institutional investors. What percentage of Immix Biopharma stock is owned by institutional investors? 11.26% of Immix Biopharma stock is owned by institutional investors. Learn more on IMMX's institutional investor holdings. Which institutional investors have been buying Immix Biopharma stock? Of the 15 institutional investors that purchased Immix Biopharma stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Private Advisor Group LLC ($99.78K), UMB Bank n.a. ($99.30K), Murchinson Ltd. ($67.20K), Koshinski Asset Management Inc. ($51.00K), Tocqueville Asset Management L.P. ($29.80K), FNY Investment Advisers LLC ($28.75K), and Invst LLC ($27K). How much institutional buying is happening at Immix Biopharma? Institutional investors have bought a total of 521,236 shares in the last 24 months. This purchase volume represents approximately $1.85M in transactions. Which Immix Biopharma major shareholders have been selling company stock? The following institutional investors have sold Immix Biopharma stock in the last 24 months: AIGH Capital Management LLC ($148.32K), Renaissance Technologies LLC ($110.82K), XTX Topco Ltd ($34.53K), Private Advisor Group LLC ($30.85K), and UMB Bank n.a. ($26.66K). How much institutional selling is happening at Immix Biopharma? Institutional investors have sold a total of 351,180 shares in the last 24 months. This volume of shares sold represents approximately $699.15K in transactions. Related Companies Design Therapeutics Institutional Ownership Eledon Pharmaceuticals Institutional Ownership COMPASS Pathways Institutional Ownership Fulcrum Therapeutics Institutional Ownership SOPHiA GENETICS Institutional Ownership Larimar Therapeutics Institutional Ownership Aurora Cannabis Institutional Ownership 4D Molecular Therapeutics Institutional Ownership Ocugen Institutional Ownership Amylyx Pharmaceuticals Institutional Ownership This page (NASDAQ:IMMX) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immix Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Immix Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IMMX Stock Alerts